Targeted treatment strategies for menstrual migraine.
Martin
Vincent
V
University of Cincinnati College of Medicine, Cincinnati, OH, USA.
D000208:Acute Disease; D000328:Adult; D016207:Cytokines / Q000627:therapeutic use; D004879:Ergotamines / Q000627:therapeutic use; D004967:Estrogens / Q000378:metabolism / Q000627:therapeutic use; D005260:Female; D055436:Growth Differentiation Factor 15; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use; D008599:Menstruation Disturbances / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism; D008881:Migraine Disorders / Q000175:diagnosis / Q000188:drug therapy* / Q000378:metabolism / Q000517:prevention & control; D014363:Tryptamines / Q000627:therapeutic use
D016207:Cytokines; D004879:Ergotamines; D004967:Estrogens; C526140:GDF15 protein, human; D055436:Growth Differentiation Factor 15; D014363:Tryptamines; D008274:Magnesium